Texas Becomes Latest State to Improve Access to Biomarker Testing

Texas Governor Greg Abbott signed Senate Bill 989 into law, making Texas the 11th state to expand access to biomarker testing. The Senate Bill 989 relates to health benefit plan coverage for certain biomarker testing.

Texas has joined a growing list of states expanding access to biomarker testing. The victory in Texas should be eye-opening to legislators across other states. Precision medicine accessibility is important to prevent the risk of worsening health disparities and missing opportunities to match patients with the most effective treatments.